-
Vivint Solar Inc (NYSE: VSLR) shares climbed 17.2
percent to $5.10. Goldman Sachs upgraded Vivint Solar from Neutral to Buy.
-
Nantkwest Inc (NASDAQ: NK) shares surged 8.3
percent to $7.67.
-
Lipocine Inc (NASDAQ: LPCN) shares gained 6.7
percent to $4.29 as the company disclosed that LPCN 1021 met its primary endpoint.
-
Invivo Therapeutics Holdings Corp (NASDAQ: NVIV)
shares climbed 5.5 percent to $2.53 as the company reported new patient enrollment into INSPIRE study at Allegheny General
Hospital.
-
Fossil Group Inc (NASDAQ: FOSL) shares gained 4.8
percent to $9.66. Buckingham upgraded Fossil Group from Underperform to Neutral.
-
Lennar Corporation (NYSE: LEN) shares rose 4.7
percent to $55.20 after the company reported stronger-than-expected results for its second quarter.
-
Bellicum Pharmaceuticals Inc (NASDAQ: BLCM)
shares rose 4.5 percent to $13.48 after surging 13.86 percent on Monday.
-
PAREXEL International Corporation (NASDAQ: PRXL)
shares gained 4.1 percent to $87.32 after WSJ reported that Pamplona Capital Management is near a deal to acquire the company
for $88.10 per share.
-
Clovis Oncology Inc (NASDAQ: CLVS) shares rose 4
percent to $91.42. Janney Capital upgraded Clovis Oncology from Neutral to Buy.
-
Marvell Technology Group Ltd. (NASDAQ: MRVL)
gained 2.5 percent to $17.86. Pacific Crest upgraded Marvell Technology from Sector Weight to Overweight.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.